Pilot Study Evaluating Panitumumab-IRDye800 as an Optical Imaging Agent to Detect Intracranial Lesions During Neurosurgical Procedures
This pilot clinical study evaluates the safety and imaging performance of panitumumab-IRDye800 (pan800), a fluorescent, EGFR-targeted imaging agent - in patients undergoing neurosurgical resection of intracranial lesions.
Subjects with intracranial lesions undergoing surgical removal as their standard... [+6]
Had a myocardial infarction, cerebrovascular accident, or uncontrolled chronic h... [+7]